The complement system, a crucial component of innate immunity, plays a multifaceted role in host defense, inflammation, and immune regulation. As research into complement-targeted therapies accelerates, the need for reliable and nuanced testing methods has become increasingly apparent. A range of specialized assays now enables scientists to evaluate complement activity with precision, supporting therapeutic development.
Hemolysis Inhibition Assay
Evaluating Inhibitor Potency Among the most informative tools for assessing complement inhibition is the hemolysis inhibition assay. This method measures the ability of therapeutic agents—such as anti-C5 antibodies or regulatory proteins like CD55 and CD59—to prevent red blood cell lysis triggered by the membrane attack complex (MAC). By quantifying the extent of inhibition, researchers can determine the functional efficacy of complement-targeting compounds. The assay supports both classical (CH50) and alternative (AH50) pathway analysis, offering flexibility for diverse experimental needs.
CH50 Functional Test Kit
Classical Pathway Assessment For laboratories focused on the classical complement pathway, the CH50 functional test remains a gold standard. This assay evaluates serum’s capacity to lyse antibody-coated erythrocytes, producing a CH50 value that reflects overall pathway activity. The test is widely used to detect complement deficiencies, monitor disease progression, and assess the impact of immunomodulatory treatments. Its compatibility with multiple species and consistent reproducibility make it a staple in both clinical and research settings.
Individual Component Activity Testing
Molecular-Level Insights While total complement activity offers a broad overview, dissecting the function of individual components provides deeper understanding. Quantitative assays such as ELISA, nephelometry, and radial immunodiffusion (RID) allow for accurate measurement of proteins like C3, C4, C5, Factor B, and Factor H. Functional assays further assess each component’s ability to restore hemolytic activity in deficient serum, offering critical insights into immune dysfunction and therapeutic mechanisms. This dual approach is particularly valuable in the study of autoimmune diseases, infections, and complement-mediated disorders.
A Trusted Partner in Complement Research
Creative Biolabs distinguishes itself through its commitment to scientific rigor, customization, and client support. Its complement testing platform is designed to meet the diverse needs of researchers, from early-stage drug discovery to translational immunology. By offering high-quality assays and expert guidance, Creative Biolabs enables scientists to explore the complexities of the complement system with confidence.
As the field of immunology continues to embrace personalized and targeted therapies, complement testing stands out as a vital tool for discovery and innovation. With robust methodologies and adaptable formats, researchers are better equipped than ever to explore the complexities of the immune system and translate findings into impactful treatments.
